SHIVALIK RASAYAN PHARMACEUTICALS COMPNY LONGTERM RANGE BREKOUT.
SHIVALIK RASAYAN ONE OF THE API MANUFACTURE NOW A DAYS ALL PHARAM STOCK AS WELL AS PHARMA INDEX LOOKS BULLISH AND GOVERNMENT ALSO INCREASED IMPORT DUTY ON API. WHICH WILL BOOST DOMESTIC PRODUCTION COMPANY FUNDAMENTAL ALSO IN LINE I PERSONALLY EXPECT THIS SHARE CAN TOUCH 600,650,700,800 + BEST BUY BETWEEN 450 TO 400 SUPPORT 250.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.